Genetic Testing

Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform

Myriad to support MD Anderson researchers studying metastatic renal cell carcinoma treatment selection and responseSALT LAKE CITY, June 12, 2023…

3 years ago

77% of Americans have used addictive behaviors or unhealthy coping mechanisms to manage their mental health, according to Myriad Genetics nationwide survey

Medication failure leads 45% of respondents with depression and/or anxiety to turn to unhealthy coping mechanisms Respondents may view these behaviors…

3 years ago

Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program

New program will increase access to affordable genetic testing while also helping to identify and elevate high-risk patient careSALT LAKE…

3 years ago

Rhythm Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference

BOSTON, April 10, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the…

3 years ago

Love for Liam Foundation Announces Formation; Names Board; Will Host Second Annual Golf Outing & Benefit Dinner on May 5, 2023

PHILADELPHIA, March 20, 2023 (GLOBE NEWSWIRE) -- The Love for Liam Foundation, a 501(c)(3) nonprofit that seeks to raise awareness…

3 years ago

GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey”

Genome Sequencing and Interpretation Services Progressing Quickly for 1,000 Newborns Enrolled in Study to Date; On Track to Support up…

3 years ago

Porex Life Sciences Institute Expands Saletto® Filtered Saliva Collection Device to the Genetic Testing Market

Revolutionary saliva collection tool standardizes samples through the industry’s first and only filtered collection tip, producing ready-to-use samples that are…

3 years ago

New 23andMe Surveys Find Most People and Doctors Agree that Genetic Testing Offers Promise for More Personalized Healthcare

92 percent of doctors in the U.S. say genetics is an important part of a patient’s complete health picture66 percent…

3 years ago

Rhythm Pharmaceuticals Announces Acquisition of Xinvento B.V. and Portfolio of Investigational Therapeutics

       - Rare disease company in preclinical development for congenital hyperinsulinism - - Acquisition is strong strategic fit…

3 years ago